博舒替尼通过抑制盐诱导激酶减轻小鼠脑出血炎症
结果显示SIK-2参与脑出血后炎症诱导,抑制SIK-2可减轻脑水肿和神经功能缺损,博舒替尼经鼻给药具有保护作用。
要点
- SIK-2在脑出血后表达降低,外源性SIK-2加重炎症和脑损伤。
- 抑制SIK-2可减轻脑出血后炎症、脑水肿和神经功能障碍。
- 博舒替尼经鼻给药通过CRTC3-CREB-NF-κB通路发挥保护作用。
核心结论
- SIK-2参与脑出血后炎症诱导,抑制SIK-2可减轻脑损伤。
- 博舒替尼或SIK-2 siRNA抑制SIK-2后减少炎症、减轻脑损伤。
- SIK-2的作用至少部分由CRTC3-CREB-NF-κB信号通路介导。
研究设计与样本
- 重组SIK-2于脑出血后1小时脑室内给药,SIK-2 siRNA于脑出血前24小时脑室内注射。
- 博舒替尼于脑出血后1小时或6小时经鼻给药。
- 通过神经学测试和脑含水量评估治疗效果,Western blot和免疫荧光研究分子通路。
主要发现
- 内源性SIK-2表达于小胶质细胞和神经元,脑出血后SIK-2表达降低。
- 外源性SIK-2加重脑出血后炎症,导致脑水肿和神经行为缺陷。
- 抑制SIK-2减轻脑出血后炎症,减少脑水肿并改善神经功能障碍。
- 博舒替尼抑制SIK-2减轻脑出血诱导的脑损伤。
临床怎么用
- 博舒替尼作为已临床批准的酪氨酸激酶抑制剂,经鼻给药在脑出血小鼠中显示保护作用。
- 靶向SIK-2可能成为脑出血后炎症干预的潜在策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Intracerebral hemorrhage (ICH) is a subtype of stroke with highest mortality and morbidity. Pronounced inflammation plays a significant role in the development of the secondary brain injury after ICH. Recently, SIK-2 (salt-inducible kinase-2) was identified as an important component controlling inflammatory response. Here we sought to investigate the role of SIK-2 in post-ICH inflammation and potential protective effects of SIK-2 inhibition after ICH. METHODS: Two hundred and ninety-three male CD-1 mice were used. ICH was induced via injection of 30 μL of autologous blood. Recombinant SIK-2 was administrated 1 hour after ICH intracerebroventricularly. SIK-2 small interfering RNA was injected intracerebroventricularly 24 hours before ICH. Bosutinib, a clinically approved tyrosine kinase inhibitor with affinity to SIK-2, was given intranasally 1 hour or 6 hours after ICH. Effects of treatments were evaluated by neurological tests and brain water content calculation. Molecular pathways were investigated by Western blots and immunofluorescence studies. RESULTS: Endogenous SIK-2 was expressed in microglia and neurons. SIK-2 expression was reduced after ICH. Exogenous SIK-2 aggravated post-ICH inflammation, leading to brain edema and the neurobehavioral deficits. SIK-2 inhibition attenuated post-ICH inflammation, reducing brain edema and ameliorating neurological dysfunctions. Bosutinib inhibited SIK-2-attenuating ICH-induced brain damage. Protective effects of Bosutinib were mediated, at least partly, by CRTC3 (cyclic amp-response element binding protein-regulated transcription coactivator 3)/cyclic amp-response element binding protein/NF-κB (nuclear factor-κB) pathway. CONCLUSIONS: SIK-2 participates in inflammation induction after ICH. SIK-2 inhibition via Bosutinib or small interfering RNA decreased inflammation, attenuating brain injury. SIK-2 effects are, at least partly, mediated by CRTC3-cyclic amp-response element binding protein-NF-κB signaling pathway.
引用
- Ma L, Manaenko A, Ou YB, et al. Bosutinib Attenuates Inflammation via Inhibiting Salt-Inducible Kinases in Experimental Model of Intracerebral Hemorrhage on Mice. Stroke. 2017. PMID: 29018127. doi:10.1161/STROKEAHA.117.017681
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。